Veljan Denison re-appoints Dr. Suresh Akella as independent director for five years
Veljan Denison Limited's Board approved the re-appointment of Dr. Suresh Akella as an Independent Director for a five-year term starting September 30, 2026. The decision, taken on August 3, 2026, follows a recommendation from the Nomination and Remuneration Committee. Shareholder approval via a Special Resolution is required to finalize the appointment, which aims to leverage Dr. Akella's expertise in Manufacturing and F&E.

*this image is generated using AI for illustrative purposes only.
Veljan Denison Limited has approved the re-appointment of Dr. Suresh Akella as a Non-Executive Independent Director for a second consecutive term, subject to shareholder approval. The Board made the decision at its meeting held on August 3, 2026, based on the recommendation of the Nomination and Remuneration Committee. The new term is scheduled to commence on September 30, 2026, and will run until September 29, 2031. This appointment ensures continuity in independent oversight for the Hyderabad-based manufacturing company.
The move follows a review of Dr. Akella’s qualifications, expertise, and experience in Manufacturing and F&E (Fabrication & Erection). The Board determined that his continued association remains beneficial to the Company’s strategic guidance and governance. The re-appointment must be ratified by shareholders through a Special Resolution. Until such approval is granted, the appointment remains conditional.
Appointment Details
The key parameters of the proposed re-appointment are outlined below:
| Particular | Detail |
|---|---|
| Appointee | Dr. Suresh Akella (DIN: 06931014) |
| Role | Non-Executive Independent Director |
| Term Duration | Five years |
| Start Date | September 30, 2026 |
| End Date | September 29, 2031 |
| Approval Status | Approved by Board; pending Shareholder Special Resolution |
Regulatory Compliance and Independence
The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company also cited compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The Board confirmed that Dr. Akella satisfies the criteria of independence prescribed under the Companies Act, 2013 and the SEBI Listing Regulations.
Furthermore, the Company stated that Dr. Akella is not related to any other Director of the Company. He is also not debarred from holding the office of Director by virtue of any order passed by the Securities and Exchange Board of India or any other authority. The Nomination and Remuneration Committee recommended the re-appointment after verifying these independence criteria.
Profile and Expertise
Dr. Suresh Akella brings extensive experience in the Manufacturing and F&E sectors to the Board. His profile highlights significant expertise in technology and industry applications. The Board noted his valuable contributions through strategic guidance and independent oversight during his previous term. This background aligns with the Company’s operational focus and governance requirements for its independent directorship roles.
Historical Stock Returns for Veljan Denison
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -4.26% | +16.62% | +68.52% | +68.52% | +68.52% |
How might Dr. Akella's continued oversight influence Veljan Denison's strategic expansion plans in the Fabrication & Erection sector over the next five years?
What are the potential implications for shareholder voting dynamics given that this re-appointment requires a Special Resolution?
Could the retention of Dr. Akella signal any upcoming shifts in the company's technology adoption or operational governance policies?


































